Algyl GGP® Next-Generation Intra-Articular Therapy | Class III Medical Device

Product description

Algyl GGP® is an innovative intra-articular treatment designed for osteoarthritis and other degenerative joint conditions.It contains hyaluronic acid (1,200 kDa), N-acetylglucosamine, and the amino acids glycine and proline — a unique combination that targets the biology of the entire joint system.The patented gel carrier ensures optimal viscoelastic properties, prolonged residence time in the joint, and an excellent balance between efficacy and tolerability.Algyl GGP® not only addresses symptoms but also supports cartilage regeneration, collagen synthesis, and modulation of inflammatory processes.
B2B potential: patented combination, strong benefit–risk profile, suitable for orthopedics, sports medicine, and specialized clinical settings.
Read more

Specifications

Categories Additives incl. Flavourings & Colours | Flavour EnhancersGlycine and its sodium salt; Bioactive Compounds - OtherHyaluronic acid
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Supplied from Czech Republic

Products from other suppliers

Algyl GGP® Next-Generation Intra-Articular Therapy | Class III Medical Device

Contact information

Address

Email

Telephone

Website

View all contact information